<p>Nutex Health Inc.（NASDAQ:NUTX - 获取免费报告）的股票在周二的交易中达到了新的 52 周高点，此前一名内部人士购买了该公司的额外股份。该公司股票最高交易价为 137.32 美元，最后交易价为 129.67 美元，成交量为 212340 股。该股票此前收盘价为 132.03 美元。</p>
<p>具体来说，首席财务官 Jon Christian Bates 在 4 月 8 日（星期二）进行的一笔交易中购买了 1000 股该股票。每股购买价格为 81.81 美元，总交易额为 81,810.00 美元。收购后，首席财务官现在持有该公司 4888 股，价值 399,887.28 美元。此次交易使其持股增加了 25.72%。该收购已在向 SEC 提交的法律文件中披露，文件可通过此链接获取。</p>
<h2>华尔街分析师观点</h2>
<p>另外，Maxim Group 在 4 月 8 日的研究报告中将 Nutex Health 的目标股价从 75.00 美元上调至 100.00 美元，并给予该股票 “买入” 评级。</p>
<p><strong>查看我们最新的 Nutex Health 股票报告</strong></p>
<h2>Nutex Health 价格表现</h2>
<p>该公司的 50 日移动平均线为 64.12 美元，200 日移动平均线为 42.85 美元。公司的流动比率为 1.77，速动比率为 1.74，债务与股本比率为 3.36。公司的市值为 7.1682 亿美元，市盈率为-13.81，贝塔值为 0.27。</p>
<p>Nutex Health（NASDAQ:NUTX - 获取免费报告）最近于 3 月 31 日（星期一）公布了季度财报。该公司报告每股收益为 11.12 美元，超出市场共识预期的（0.09 美元）11.21 美元。Nutex Health 的股本回报率为-51.27%，净利润率为-14.09%。该公司在本季度的收入为 8130 万美元，而市场共识预期为 8113 万美元。</p>
<h2>机构投资者对 Nutex Health 的看法</h2>
<p>大型投资者最近增加或减少了对该公司的持股。Topline Capital Management LLC 在第四季度购买了 Nutex Health 的新股份，价值约 569 万美元。American Century Companies Inc.在第四季度购买了 Nutex Health 的新头寸，价值约 136.2 万美元。Ancora Advisors LLC 在第四季度购买了 Nutex Health 的新股份，价值约 133.4 万美元。Drive Wealth Management LLC 在第四季度购买了 Nutex Health 的新股份，价值约 112.2 万美元。最后，Essex Investment Management Co. LLC 在第四季度将其在 Nutex Health 的持股增加了 45.4%。Essex Investment Management Co. LLC 目前持有该公司 105,809 股股票，价值 335.3 万美元，此前在上个季度又购买了 33,024 股。机构投资者持有该公司 5.32% 的股份。</p>
<h2>关于 Nutex Health</h2>
<p>（获取免费报告）</p>
<p>Nutex Health Inc 是一家由医生主导的医疗服务和运营公司。它通过三个部门运营：医院、人口健康管理（PHM）和房地产。PHM 部门建立和运营独立的医生协会；并为医疗组织提供基于云的平台，以提供基于价值的护理和人口健康管理。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 Nutex Health 更好</li>
<li>卖空 - 利弊分析</li>
<li>为什么 NVIDIA 股票可能会在华尔街下调评级后飙升</li>
<li>3 只天然气股票提供优厚的股息收益</li>
<li>第一季度内部人士购买的三只大型股：买入、卖出还是持有</li>
<li>交易暂停解释</li>
<li>3 只热新 IPO 逆势而上，抵御 2025 年市场下滑</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Nutex Health 吗？</h2>
<p>在考虑 Nutex Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买...而 Nutex Health 并不在名单上。</p>
<p>虽然 Nutex Health 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

NUTX

<p>Nutex Health（纳斯达克代码：NUTX）在首席财务官 Jon Christian Bates 的内部购买后，达到了新的 52 周高点 137.32 美元，他以每股 81.81 美元购买了 1,000 股。该股票最后交易于 129.67 美元。Maxim Group 将其目标价从 75 美元上调至 100 美元，维持 “买入” 评级。Nutex 报告每股收益为 11.12 美元，超出预期，收入为 8130 万美元。机构投资者持有该公司 5.32% 的股份，该公司在医疗服务领域运营，分为三个部门：医院、人口健康管理和房地产</p>

<p>Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) reached a new 52-week high during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $137.32 and last traded at $129.67, with a volume of 212340 shares. The stock had previously closed at $132.03.</p>
<div class="lb-trans"><p>Nutex Health Inc.（NASDAQ:NUTX - 获取免费报告）的股票在周二的交易中达到了新的 52 周高点，此前一名内部人士购买了该公司的额外股份。该公司股票最高交易价为 137.32 美元，最后交易价为 129.67 美元，成交量为 212340 股。该股票此前收盘价为 132.03 美元。</p>
</div><p>Specifically, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the acquisition, the chief financial officer now owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>具体来说，首席财务官 Jon Christian Bates 在 4 月 8 日（星期二）进行的一笔交易中购买了 1000 股该股票。每股购买价格为 81.81 美元，总交易额为 81,810.00 美元。收购后，首席财务官现在持有该公司 4888 股，价值 399,887.28 美元。此次交易使其持股增加了 25.72%。该收购已在向 SEC 提交的法律文件中披露，文件可通过此链接获取。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Separately, Maxim Group lifted their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a &#34;buy&#34; rating in a research report on Tuesday, April 8th.</p>
<div class="lb-trans"><p>另外，Maxim Group 在 4 月 8 日的研究报告中将 Nutex Health 的目标股价从 75.00 美元上调至 100.00 美元，并给予该股票 “买入” 评级。</p>
</div><p><strong>View Our Latest Stock Report on Nutex Health</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Nutex Health 股票报告</strong></p>
</div><h2>Nutex Health Price Performance</h2>
<div class="lb-trans"><h2>Nutex Health 价格表现</h2>
</div><p>The firm has a fifty day moving average of $64.12 and a two-hundred day moving average of $42.85. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The company has a market capitalization of $716.82 million, a PE ratio of -13.81 and a beta of 0.27.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均线为 64.12 美元，200 日移动平均线为 42.85 美元。公司的流动比率为 1.77，速动比率为 1.74，债务与股本比率为 3.36。公司的市值为 7.1682 亿美元，市盈率为-13.81，贝塔值为 0.27。</p>
</div><p>Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.</p>
<div class="lb-trans"><p>Nutex Health（NASDAQ:NUTX - 获取免费报告）最近于 3 月 31 日（星期一）公布了季度财报。该公司报告每股收益为 11.12 美元，超出市场共识预期的（0.09 美元）11.21 美元。Nutex Health 的股本回报率为-51.27%，净利润率为-14.09%。该公司在本季度的收入为 8130 万美元，而市场共识预期为 8113 万美元。</p>
</div><h2>Institutional Investors Weigh In On Nutex Health</h2>
<div class="lb-trans"><h2>机构投资者对 Nutex Health 的看法</h2>
</div><p>Large investors have recently added to or reduced their stakes in the company. Topline Capital Management LLC purchased a new stake in shares of Nutex Health during the fourth quarter worth about $5,690,000. American Century Companies Inc. bought a new position in Nutex Health during the 4th quarter valued at approximately $1,362,000. Ancora Advisors LLC purchased a new stake in Nutex Health in the 4th quarter worth approximately $1,334,000. Drive Wealth Management LLC purchased a new stake in Nutex Health in the 4th quarter worth approximately $1,122,000. Finally, Essex Investment Management Co. LLC grew its position in shares of Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. Institutional investors own 5.32% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近增加或减少了对该公司的持股。Topline Capital Management LLC 在第四季度购买了 Nutex Health 的新股份，价值约 569 万美元。American Century Companies Inc.在第四季度购买了 Nutex Health 的新头寸，价值约 136.2 万美元。Ancora Advisors LLC 在第四季度购买了 Nutex Health 的新股份，价值约 133.4 万美元。Drive Wealth Management LLC 在第四季度购买了 Nutex Health 的新股份，价值约 112.2 万美元。最后，Essex Investment Management Co. LLC 在第四季度将其在 Nutex Health 的持股增加了 45.4%。Essex Investment Management Co. LLC 目前持有该公司 105,809 股股票，价值 335.3 万美元，此前在上个季度又购买了 33,024 股。机构投资者持有该公司 5.32% 的股份。</p>
</div><h2>About Nutex Health</h2>
<div class="lb-trans"><h2>关于 Nutex Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.</p>
<div class="lb-trans"><p>Nutex Health Inc 是一家由医生主导的医疗服务和运营公司。它通过三个部门运营：医院、人口健康管理（PHM）和房地产。PHM 部门建立和运营独立的医生协会；并为医疗组织提供基于云的平台，以提供基于价值的护理和人口健康管理。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Nutex Health</li>
<li>Short Selling - The Pros and Cons</li>
<li>Why NVIDIA Stock Could Soar Despite Wall Street Downgrades</li>
<li>3 Natural Gas Stocks That Offer Great Dividend Yields</li>
<li>Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold</li>
<li>Trading Halts Explained</li>
<li>3 Hot New IPOs Defying the 2025 Market Slump</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Nutex Health 更好</li>
<li>卖空 - 利弊分析</li>
<li>为什么 NVIDIA 股票可能会在华尔街下调评级后飙升</li>
<li>3 只天然气股票提供优厚的股息收益</li>
<li>第一季度内部人士购买的三只大型股：买入、卖出还是持有</li>
<li>交易暂停解释</li>
<li>3 只热新 IPO 逆势而上，抵御 2025 年市场下滑</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Nutex Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Nutex Health 吗？</h2>
</div><p>Before you consider Nutex Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Nutex Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买...而 Nutex Health 并不在名单上。</p>
</div><p>While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Nutex Health 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Nutex Health（NASDAQ:NUTX）在内部人士买入活动后创下新的一年高点